OptimizeRx Corp (OPRX) Stock Price, Financials & Summary

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$7.50

From 52W high−66.37%

Volume233675.00

Market cap$137.31M

P/E (TTM)29.9x

P/S (TTM)1.4x

Div yield—

Key dataSep 18, 2026

Open

$7.50

From 52W high

−66.37%

Volume

233675.00

Market cap

$137.31M

ValuationView details →

P/E (Fwd)

8.2x

EV/EBITDA

8.5x

P/E (TTM)

29.9x

RSI (14)

46.9

MomentumView details →

1D Return

−3.95%

YTD Return

−39.97%

SummaryUpdated Jun 1, 2026

OptimizeRx Corporation (NASDAQ:OPRX) is a digital health technology company founded in 2006 and headquartered in Rochester, Michigan. The company went public in 2007 and has evolved from a basic electronic prescription messaging service into a comprehensive digital health platform that connects pharmaceutical manufacturers with healthcare providers and patients. OptimizeRx operates at the intersection of healthcare technology and pharmaceutical marketing, leveraging its proprietary point-of-care network to facilitate targeted communications and improve medication adherence across the healthcare ecosystem.

Ask drillr about OptimizeRx Corp →

ValuationView details →

P/E (Fwd)

8.2x

P/E (TTM)

29.9x

EV/EBITDA

8.5x

EV/Sales

1.3x

P/S (TTM)

1.4x

P/B (TTM)

1.0x

ProfitabilityView details →

Gross Margin

72.14%

Net Margin

4.66%

EBITDA Margin

15.82%

ROE (TTM)

3.51%

ROA (TTM)

2.80%

Asset Turnover

0.60x

GrowthView details →

Revenue YoY

−5.82%

EPS YoY

+145.01%

FCF YoY

+80.59%

Revenue CAGR 3Y

+20.56%

EPS CAGR 3Y

+125.45%

EBITDA YoY

+1400.38%

MomentumView details →

1D Return

−3.95%

YTD Return

−39.97%

1Y Return

−59.56%

RSI (14)

46.9

vs 50D SMA

+1.75%

vs 200D SMA

−8.16%

Capital & dividendView details →

Debt/Equity

0.15x

Current Ratio

5.58x

Quick Ratio

5.58x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

$0.16

EPS Surprise

44.01%

Beats (12Q)

10/12

Next Q EPS Est

$0.18

Avg Surprise (4Q)

508.11%

Rev Surprise

1.46%

Financials snapshotView financials →

Revenue (TTM)

98.65M

Net Income (TTM)

4.60M

Op. CF (TTM)

18.43M

Next earningsNov 5, 2026 →

Latest newsMore news →

OptimizeRx expanded its Natural Language Audience Builder to unify HCP and DTC audience intelligence for DSPs and agency planners.6d ago

OptimizeRx announced the appointments of Andy D'Silva as Chief Financial Officer and Heather Favazza as Chief Accounting Officer, effective January 1, 2027.39d ago

Similar companies

Health Catalyst, Inc.HCAT Definitive Healthcare Corp.DH CareCloud, Inc.CCLD Spok Holdings, Inc.SPOK American Well CorporationAMWL So-Young International Inc.SY Find similar companies →

Latest newsMore news →

OptimizeRx expanded its Natural Language Audience Builder to unify HCP and DTC audience intelligence for DSPs and agency planners.6d ago OptimizeRx announced the appointments of Andy D'Silva as Chief Financial Officer and Heather Favazza as Chief Accounting Officer, effective January 1, 2027.39d ago